Authors: Fukui, Michiaki; Kitagawa, Yoshihiro; Ose, Hiroyuki; Hasegawa, Goji; Yoshikawa, Toshikazu; Nakamura, Naoto

Source: Current Diabetes Reviews, Volume 3, Number 1, February 2007 , pp. 25-31(7)

Publisher: Bentham Science Publishers

Abstract:

Age-related decline in serum testosterone and dehydroepiandrosterone sulfate concentrations occur in men. Low concentrations of these endogenous androgens have been linked with insulin resistance, which is an important upstream driver for metabolic abnormalities such as hyperglycemia, hypertension, or hyperlipidemia, and increased cardiovascular risk. Moreover, men with diabetes have significantly less circulating androgen than nondiabetic men. Here, we summarize how androgen affects insulin resistance and atherosclerosis in men with type 2 diabetes. Low serum concentrations of endogenous androgens are associated with visceral fat accumulation. Androgen deprivation by castration to treat prostate cancer increases insulin resistance, while testosterone administration in type 2 diabetic men with androgen deficiency improves glucose homeostasis and decreases visceral fat, in addition to alleviating symptoms of androgen deficiency including erectile dysfunction. Androgen correlates inversely with severity of atherosclerosis and has beneficial effects upon vascular reactivity, inflammatory cytokine, adhesion molecules, insulin resistance, serum lipids, and hemostatic factors. Because men with type 2 diabetes have relative hypogonadism, testosterone supplementation could decrease both insulin resistance and atherosclerosis.

Keywords: Testosterone; Dehydroepiandrosterone; Insulin resistance; Atherosclerosis; Type 2 diabetes; Men

Document Type: Research article

DOI: http://dx.doi.org/10.2174/157339907779802094

Affiliations: 1: Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji,Kamigyo-ku, Kyoto 602-8566, Japan.

Publication date: 2007-02-01

More about this publication?

• Current Diabetes Reviews publishes frontier reviews on all the latest advances on diabetes and its related areas e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy.
  
  The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.

Related content

• In this: publication
• By this: publisher
• In this Subject: Medicine ,  Medicine (General)
• By this author: Fukui, Michiaki ;  Kitagawa, Yoshihiro ;  Ose, Hiroyuki ;  Hasegawa, Goji ;  Yoshikawa, Toshikazu ;  Nakamura, Naoto

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers